BSX Boston Scientific Corporation | US1011371077
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 65.771.216.896 | 93.264.967.513,25 | 141.404.077.963,07 | 144.715.312.652,82 |
| Enterprise Value | 75.587.215.360 | 102.840.967.513,25 | 150.875.077.963,07 | 155.486.312.652,82 |
| Trailing P/E | 18,51 | 26,16 | 48,79 | 65,01 |
| Forward P/E | 11,92 | - | - | - |
| Price to Sales | 3,19 | 4,52 | 7,04 | 9,79 |
| Price to Book | 2,54 | 3,61 | 5,84 | 6,19 |
| EV/Revenue | 3,67 | 4,99 | 7,52 | 10,51 |
| EV/EBITDA | 13,74 | 18,1 | 28,29 | 38,03 |